InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hahn Mark W, Chief Financial Officer. Director active across 1 company, notably Verona Pharma plc. In total, 38 reports have been recorded. Split: 0 buy · 17 sells. Total volume traded: €9.8m. Activity tracked since 3 May 2021. The latest transaction was disclosed on 1 May 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations38 total
108,272 shares@ US$8.95024.7% of flowOrdinary SharesSEC:0001104659-25-044536:0
229,512 shares0Ordinary SharesSEC:0001104659-25-043645:0
200,000 shares0Ordinary SharesSEC:0001104659-25-009142:0
58,184 shares@ US$5.00131.5% of flowOrdinary SharesSEC:0001104659-24-126371:0
12,936 shares@ US$5.000.3% of flowOrdinary SharesSEC:0001104659-24-124757:0
1,600 shares@ US$5.000.0% of flowOrdinary SharesSEC:0001104659-24-123211:0
2,400 shares@ US$5.000.1% of flowOrdinary SharesSEC:0001104659-24-117791:0
48,888 shares@ US$4.37611.1% of flowOrdinary SharesSEC:0001104659-24-114409:0
800,000 shares0Ordinary SharesSEC:0001104659-24-113576:0
141,360 shares@ US$4.37723.1% of flowOrdinary SharesSEC:0001104659-24-111567:0
249,728 shares@ US$4.38075.5% of flowOrdinary SharesSEC:0001104659-24-110658:0
600,000 shares@ US$3.756811.2% of flowOrdinary SharesSEC:0001104659-24-099790:0
1,600 shares@ US$3.130.0% of flowOrdinary SharesSEC:0001104659-24-089639:0
800,000 shares0Ordinary SharesSEC:0001104659-24-087926:0
88,544 shares@ US$2.83251.3% of flowOrdinary SharesSEC:0001104659-24-086003:0
88,544 shares@ US$1.93130.9% of flowOrdinary SharesSEC:0001104659-24-057115:0
480,664 shares@ US$2.29385.6% of flowOrdinary SharesSEC:0001104659-24-010783:0
809,008 shares@ US$1.74387.3% of flowOrdinary SharesSEC:0001104659-23-114404:0
800,000 shares0Ordinary SharesSEC:0001104659-23-111090:0
117,272 shares@ US$2.5391.5% of flowOrdinary SharesSEC:0001104659-23-088491:0
105,944 shares@ US$2.6791.4% of flowOrdinary SharesSEC:0001104659-23-087445:0
455,528 shares@ US$2.57595.9% of flowOrdinary SharesSEC:0001104659-23-055647:0
413,168 shares@ US$2.55725.3% of flowOrdinary SharesSEC:0001104659-23-010735:0
600,000 shares@ US$2.11516.6% of flowOrdinary SharesSEC:0001104659-22-129083:0
454,856 shares@ US$1.604.0% of flowOrdinary SharesSEC:0001104659-22-114412:0
25 of 38 declarations
About Hahn Mark W
Mark W. Hahn is the Chief Financial Officer at Verona Pharma plc. He oversees the financial management of the company, including financial planning and reporting. With a strong background in the pharmaceutical sector, he plays a key role in formulating financial strategies aimed at supporting Verona Pharma's growth and innovation.
